Author

M. Dandri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

L. Allweiss· 3 shared A. S. Perelson· 2 shared K. Aihara· 2 shared K. Kitagawa· 2 shared K. Watashi· 2 shared M. Iwamoto· 2 shared M. Luetgehetmann· 2 shared N. Nakamura· 2 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

L. Allweiss

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation for analyzing extracellular viral markers

K. Kitagawa, K. Kim, M. Iwamoto, S. Hayashi, H. Park, T. Nishiyama, N. Nakamura, Y. Fujita, S. Nakaoka, K. Aihara, A. S. Perelson, L. Allweiss, M. Dandri, K. Watashi, Y. Tanaka, S. Iwami

This study develops a multiscale mathematical model to predict intrahepatic cccDNA dynamics using serum viral markers, offering a non-invasive method for HBV infection analysis.

bioRxiv · Jun 6, 2023 · PreprintMicrobiology

Prediction of elimination of intrahepatic cccDNA in hepatitis B virus-infected patients by a combination of noninvasive viral markers

S. Iwami, M. Iwamoto, T. Wakita, K. Watashi, A. S. Perelson, Y. Tanaka, M. Dandri, K. Aihara, M. Muramatsu, S. Iwami, E. Kawakami, L. Allweiss, P. Tangkijvanich, N. Chuaypen, M. Atsukawa, , Y. Fujita

This study develops a noninvasive method using viral markers to predict cccDNA levels in HBV patients, validated against liver biopsy data.

bioRxiv · Nov 4, 2022 · PreprintMicrobiology

The potent broadly neutralizing antibody VIR-3434 controls Hepatitis B and D Virus infection and reduces HBsAg in humanized mice

F. A. Lempp, T. Volz, E. Cameroni, F. Benigni, J. Zhou, L. E. Rosen, J. Noack, F. Zatta, H. Kaiser, S. Bianchi, G. Lombardo, S. Jaconi, H. Imam, L. B. Soriaga, N. Passini, , M. A. Schmid

This paper identifies a potent anti-HBs mAb, VIR-3434, that neutralizes HBV and HDV and reduces HBsAg and viremia in human liver-chimeric mice.

bioRxiv · Sep 9, 2022Microbiology

SARS-CoV-2 infects carotid arteries: implications for vascular disease and organ injury in COVID-19

S. Pfefferle, T. Guenther, V. Puelles, F. Heinrich, D. Noerz, M. Czech-Sioli, A. Carstens, S. Krasemann, M. Wong, L. Oestereich, T. Magnus, L. Allweiss, C. Edler, A.-S. Schroeder, M. Dandri, , N. Fischer

The paper investigates SARS-CoV-2 infection in carotid arteries of COVID-19 patients using genomic, virologic, histochemical, and transcriptomic analyses, showing productive infection and vascular modulation.

bioRxiv · Oct 10, 2020 · PreprintMicrobiology